Stocks · US
INSM
XNAS
Insmed, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B29.93x
P/S19.93x
EPS$-4.01
ROE-115.55%
ROA-41.63%
Dividend yield0.00%
Debt/Equity0.75
Free cash flow$-808M
Returns and 52-week range
1W-8.99%
1M-16.68%
3M-9.70%
6M-35.45%
1Y-33.04%
YTD-40.59%
52W high$212.75
52W low$90.39
From 52W high-50.54%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| United Therapeutics Corp | $23.0B | 17.55 | 3.59 | +11.08% |
| Tenet Healthcare Corporation New | $20.9B | 9.32 | 4.49 | -2.48% |
| Incyte Genomics Inc | $23.1B | 14.35 | 3.65 | -11.06% |
| STERIS plc | $20.6B | 25.56 | 2.86 | -7.10% |
| 랩코프 | $25.0B | 24.97 | 2.91 | -4.64% |
| 비아트리스 | $20.2B | — | 1.42 | +3.91% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.